Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Injective

Fintech · New York City, United States · Founded 2018 Unicorn

Develops a fully-decentralized exchange protocol that eliminates front-running and allows for trustless liquidity sharing

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value
Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

8 investors on Injective's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 7 investors entered at this stage
BoxOne Ventures
Pantera Capital
The Cabin Capital
BitScale
QCP Soteria
Krypital Group
Innovating Capital
Series B+ 1 investor entered at this stage
Jump Crypto

Ownership

Who owns Injective

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

56.5% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Injective has talent and traffic

Workforce by country
30 countries with
team presence
🇺🇸 United States23.9%
🇳🇬 Nigeria9.4%
🇮🇳 India5.7%
🇸🇬 Singapore4.6%
🇮🇩 Indonesia4.4%
Top 5 of 30 shown
Web traffic by country
2.6K monthly visits
across markets
🇮🇩 Indonesia100%
Top 1 markets shown

Talent graph

The shape of Injective's talent

Dealroom maps Injective's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

23 standout operatorsDealroom-flagged across the org
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Injective's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Capital deployed

Injective's 3 investments and acquisitions.

Every disclosed deal where Injective appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Injective's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Injective's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Injective

        An AI-synthesized read of the highest-engagement posts about Injective on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Injective on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles